BRCA2


Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to BRCA2: BRCA1
AcronymDefinition
BRCA2Breast Cancer Gene 2
References in periodicals archive ?
RDX, a single source for care quality, risk evaluation and opioid expertise powered by a fast, full-service laboratory, raises awareness that these gene mutations are heritable, can be passed from parent to child, and 70% of women with mutations in BRCA1 or BRCA2 will develop breast cancer before the age of 80.
Tabrizi also said that breast and ovarian cancer risk before the age of 30 is relatively low, even for carriers of BRCA1 and BRCA2 mutations.
Patients who agreed to BRCA1 and BRCA2 genetic testing were asked to complete a questionnaire regarding their family histories.
"Rather than being a barrier to transitioning, genetic counseling can benefit transgender individuals at risk for BRCA1 or BRCA2 mutations by helping them understand their cancer risks and the choices available to them to manage those risks," says Sacca.
While mutations of BRCA1 and BRCA2 were detected in five and five breast cancer cases respectively, they were one and two in individuals at risk.
The normal function of BRCA1 and BRCA2 genes is DNA repair, transcription and recombination, all of which prevent cancer development as part of the tumor suppressor group of genes.
Prior to the study, it was believed that these drugs were only effective for women with an inherited BRCA1 or BRCA2 mutation.
As a proof of principle, we focused on BRCA1 and BRCA2. Since the discovery that pathogenic variants in BRCA1 and BRCA2 genes predispose to hereditary breast and ovarian cancer, variant analysis of these genes has been offered to women with a concerning family history, and even population screening is suggested (10).
Only one year after this gene was discovered, the association between BRCA2 and pancreatic cancer was assessed by Schutte et al.
Among 1,083 women with deleterious mutations in BRCA1, BRCA2, or both who underwent risk-reducing salpingo-oophorectomy (RRSO) without hysterectomy, there was no overall increase in the incidence of uterine corpus cancers, compared with the background population.
Austin, TX, June 16, 2016 --(PR.com)-- Bioo Scientific recently launched the NEXTflex[TM] BRCA1 and BRCA2 Amplicon Panel for FFPE Illumina-Compatible Sequencing, for the detection of clinically relevant somatic mutations in DNA isolated from FFPE samples, to facilitate variant discovery and confirmation.